Halogenated selective androgen receptor modulators and methods of use thereof

Details for Australian Patent Application No. 2003287074 (hide)

Owner University of Tennessee Research Foundation

Inventors Miller, Duane D.; Yin, Donghua; Steiner, Mitchell S.; Dalton, James T.; Veverka, Karen A.; He, Yali

Agent Griffith Hack

Pub. Number AU-B-2003287074

PCT Number PCT/US2003/0325

PCT Pub. Number WO2004/035736

Priority 10/270,732 16.10.02 US; 10/371,213 24.02.03 US

Parent 2001285230

Filing date 14 October 2003

Wipo publication date 4 May 2004

Acceptance publication date 10 December 2009

International Classifications

C07C 235/16 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/404 (2006.01)

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/661 (2006.01) - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61P 5/28 (2006.01) Drugs for disorders of the endocrine system

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 15/16 (2006.01) Drugs for genital or sexual disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

C07C 235/24 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 255/60 (2006.01) Carboxylic acid nitriles

C07C 335/18 (2006.01) Thioureas, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 215/227 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 271/12 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

G01N 33/543 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with an insoluble carrier for immobilising immunochemicals

G01N 33/74 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving hormones

C07D 215/22 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 10/270,732 16.10.02 US; 10/371,213 24.02.03 US

10 June 2004 Application Open to Public Inspection

  Published as AU-B-2003287074

15 June 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 May 2006

10 December 2009 Application Accepted

  Published as AU-B-2003287074

8 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287075-TREATING OBESITY WITH SELECTIVE ANDROGEN RECEPTOR MODULATORS

2003287073-System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or modelbased controller coupled to a singleneedle or multi-needle intradermal (ID) delivery device